503B Manufacturer for Veterinary Medications & Animal Health

Controlled Substances 101: How & Why You Must Comply! Parts 1, 2 and 3

Like & Share
Tweet
Share
March 5 | 6 p.m. ET

RACE-Approved CE Credit Hours: 3
Free to attend

This session will teach attendees how to protect their people, their practice, and their profit with effective, risk reducing suggestions from a previous veterinary practice owner, consultant & public speaker/educator, who has worked with Veterinarians cited by the DEA.

Sign up for updates.

Get the latest posts and Epicur updates direct to your inbox.

Featured Posts:

The Referral Dilemma: Choosing the Best Partners in Veterinary Medicine

The following blog is written by Epicur Pharma’s Advisory Council member Debbie Boone, BS, CVPM. With over 23 years of in-clinic experience managing AAHA-accredited hospitals, Debbie understands the processes and systems a thriving practice must have in place – and what it takes to implement them. Debbie shares her perspective on referrals, and how veterinary professionals can ensure integrity and reliability through careful selection of the companies they utilize and endorse for crucial medications.

Read More »

Innovating Pain Management in Veterinary Research Medicine

Epicur Pharma recently partnered with two passionate veterinary research professionals, Dr. Daniel D. Myers Jr., DVM, MPH, DACLAM, and Dr. Patrick A. Lester, DVM, MS, BCPS, DACLAM, to bring a groundbreaking analgesic solution to market for research animals: Buprenorphine Extended Release. We sat down with them to reflect on their path to partnering with us and their hopes for the future of veterinary medicine.

Read More »